EDIT: Editas Medicine Inc

2.52 USD 0.12 (4.55%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de EDIT de hoy ha cambiado un -4.55%. En este caso, el precio mínimo en el mercado ha alcanzado 2.50, mientras que el máximo ha alcanzado 2.72.

Siga la dinámica de la pareja de divisas Editas Medicine Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

EDIT News

Zacks 21:40 MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
Seeking Alpha 20:57 Editas Medicine - Primed For An Unlikely Comeback? It's Not Impossible
Zacks 13:44 3 Genomics Stocks Worth Adding to Your Portfolio in 2025
The Motley Fool 09:04 Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?
The Motley Fool 12:15 2 Beaten-Down Stocks to Avoid
Benzinga 17:59 Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst - Eli Lilly (NYSE:LLY), Verve Therapeutics (NASDAQ:VERV)
The Motley Fool 14:07 Editas Medicine Is Great. Here's Why You Shouldn't Buy It.
Investor's Business Daily 13:14 Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
Investing 06:12 Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hema
Investing 20:55 nucana plc announces annual report release and upcoming agm
Investing 21:40 editas medicine amends stock plan and increases authorized shares
The Motley Fool 10:00 1 Stock Down 97% That Could Double, According to Wall Street
Investing 17:59 Chardan cuts Prime Medicine stock target to $12, maintains Buy
Investing 13:50 Cantor maintains Overweight on Astria stock with $47 target
Investing 13:45 Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
Investing 01:03 Editas Medicine at BofA Securities 2025: In Vivo Gene Editing Focus
Seeking Alpha 08:44 CRISPR And Intellia: Balancing Market Uncertainty Against Pipeline Catalysts (NASDAQ:CRSP)
Seeking Alpha 20:07 Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript)
Seeking Alpha 16:19 Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript)
Seeking Alpha 22:01 Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference Transcript

Rango diario

2.50 2.72

Rango anual

0.91 5.45

Cierres anteriores: 2.59
Open: 2.64

Bid: 2.52
Ask: 2.82

Low: 2.50
High: 2.72

Volumen: 3.720 K

Cambio diario: -4.55%
Cambio mensual: 16.67%

Cambio a 6 meses: 100.00%
Cambio anual: -53.42%

31 julio, jueves